Lung Cancer

Page 1 of 3 | Results 1 - 10 of 28

A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients with Hormone Receptor-Positive Advanced Breast Cancer

Estrogen can cause the growth of breast cancer cells. Endocrine therapy using exemestane may fight breast cancer by lowering the amount of estrogen...
Breast Cancer
Amaryllis Gil, MD
Accepting Participants

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

Breast Cancer
Alexander Hantel, MD

Naperville, Plainfield

Accepting Participants

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants

Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer (NSCLC)

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

Breast Cancer
Christine Gresik, MD

Naperville, Plainfield

Accepting Participants

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e^3 Breast Cancer Study-Evaluating Everolimus with Endocrine Therapy.

This randomized phase III trial studies how well giving hormone therapy together with or without everolimus work in treating patients with breast...
Breast Cancer
Amaryllis Gil, MD

Elmhurst Hospital

Accepting Participants

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

Breast Cancer
Joseph Kash, MD

Naperville, Plainfield

Pending IRB Approval for Recruiting
Page 1 of 3 | Results 1 - 10 of 28